Heterologous COVID-19 Vaccination Enhances Immune Responses
In recipients of one dose of AstraZeneca ChAdOx-1-S vaccine, the Pfizer-BioNTech BNT162b2 vaccine produced an augmented response. Several COVID-19 vaccines, such as mRNA vaccines (authorized